Viewing Study NCT07283692


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2025-12-25 @ 1:41 PM
Study NCT ID: NCT07283692
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-12-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
Sponsor: RenJi Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module